메뉴 건너뛰기
Clinical Trials
Volumn 2, Issue 3, 2005, Pages 195-196
Ethics and evidence in clinical trials

(1)  Goodman, Steven N a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EDITORIAL; EVIDENCE BASED MEDICINE; MEDICAL PRACTICE; METHODOLOGY; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RESEARCH ETHICS; SYSTEMATIC REVIEW;
EID: 21344441981     PISSN: 17407745     EISSN: None     Source Type: Journal    
DOI: 10.1191/1740774505cn083ed     Document Type: Editorial
Times cited : (5)
References (11)
  • 1
    • 21344435080 scopus 로고    scopus 로고
    • Randomized controlled trials of aprotinin in cardiac surgery: Could clinical equipoise have stopped the bleeding?
    • Fergusson D, Glass K, Hutton B, Shapiro S. Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding? Clinical Trials 2005; 2: 218-232.
    • (2005) Clinical Trials , vol.2 , pp. 218-232
    • Fergusson, D.1    Glass, K.2    Hutton, B.3    Shapiro, S.4
  • 2
    • 21344474046 scopus 로고    scopus 로고
    • The scandalous failure of science to cumulate evidence scientifically
    • Chalmers I. The scandalous failure of science to cumulate evidence scientifically. Clinical Trials 2005; 2: 229-231.
    • (2005) Clinical Trials , vol.2 , pp. 229-231
    • Chalmers, I.1
  • 3
    • 0038298712 scopus 로고    scopus 로고
    • Ethics and equipoise: Rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention
    • Tcheng JE, Madan M, O'Shea JC, et al. Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention. J Interv Cardiol 2003; 16: 97-105.
    • (2003) J Interv Cardiol , vol.16 , pp. 97-105
    • Tcheng, J.E.1    Madan, M.2    O'Shea, J.C.3
  • 4
    • 21344470177 scopus 로고    scopus 로고
    • Equipoise in the enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT) trial: A critical appraisal
    • Mann H, London A, Mann J. Equipoise in the enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT) trial: a critical appraisal. Clinical Trials 2005; 2: 233-243.
    • (2005) Clinical Trials , vol.2 , pp. 233-243
    • Mann, H.1    London, A.2    Mann, J.3
  • 5
    • 21344472923 scopus 로고    scopus 로고
    • Response to "Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT) trial: A critical appraisal"
    • Tcheng JE. Response to "Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT) trial: a critical appraisal". Clinical Trials 2005; 2: 241-242.
    • (2005) Clinical Trials , vol.2 , pp. 241-242
    • Tcheng, J.E.1
  • 6
    • 0033782056 scopus 로고    scopus 로고
    • The ambiguity and the exigency: Clarifying 'standard of care' arguments in international research
    • London AJ. The ambiguity and the exigency: clarifying 'standard of care' arguments in international research. J Med Philos 2000; 25: 379-97.
    • (2000) J Med Philos , vol.25 , pp. 379-397
    • London, A.J.1
  • 8
    • 21344447080 scopus 로고    scopus 로고
    • Where's the utility in Bayesian data-monitoring in clinical trials?
    • Ashby D, Tan S-B. Where's the utility in Bayesian data-monitoring in clinical trials? Clinical Trials 2005; 2: 197-208.
    • (2005) Clinical Trials , vol.2 , pp. 197-208
    • Ashby, D.1    Tan, S.-B.2
  • 9
    • 21344450770 scopus 로고    scopus 로고
    • Systematic review results are underused in designing new studies
    • Cooper NJ, Jones DR, Sutton AJ. Systematic review results are underused in designing new studies. Clinical Trials 2005; 2: 260-264.
    • (2005) Clinical Trials , vol.2 , pp. 260-264
    • Cooper, N.J.1    Jones, D.R.2    Sutton, A.J.3
  • 10
    • 21344447310 scopus 로고    scopus 로고
    • Abstracts presented at the American Society of Clinical Oncology conference: How well are trials reported?
    • Hopewell S, Clarke M. Abstracts presented at the American Society of Clinical Oncology conference: how well are trials reported? Clinical Trials 2005; 2: 265-268.
    • (2005) Clinical Trials , vol.2 , pp. 265-268
    • Hopewell, S.1    Clarke, M.2
  • 11
    • 21344459830 scopus 로고    scopus 로고
    • A critical history of individual and collective ethics in the lineage of Lellouch and Schwartz
    • Heilig CM, Weijer C. A critical history of individual and collective ethics in the lineage of Lellouch and Schwartz. Clinical Trials 2005; 2: 244-253.
    • (2005) Clinical Trials , vol.2 , pp. 244-253
    • Heilig, C.M.1    Weijer, C.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.